One of the most common neurological diseases is epilepsy, which not only negatively affects the quality of people’s life but also may lead to life-threatening situations when its symptoms such as seizures cannot be controlled medically. A very serious problem to be overcame is the untreatable form of this disease, which cannot be cured by any currently available medicines. Cannabidiol, which is a natural product obtained from Cannabis Sativa, brings a new hope to people suffering from drug-resistant epilepsy. However, the hydrophobic character of this compound significantly lowers its clinical efficiency. One of the promising methods of this substance bioactivity increase is delivery through the skin tissue. In this article, a new type of advanced transdermal systems based on chitosan and ZnO nanoparticles (NPs) has been developed according to Sustained Development principles. The chemical modification of the biopolymer confirmed by FT-IR method resulted in the preparation of the material with great swelling abilities and appropriate water vapor permeability. Obtained nanoparticles were investigated over their crystalline structure and morphology and their positive impact on drug loading capacity and cannabidiol controlled release was proved. The novel biomaterials were confirmed to have conductive properties and not be cytotoxic to L929 mouse fibroblasts.

Massive blood loss is still a great challenge for modern medicine. To stop the hemorrhage during the surgery or after injury apart from suturing or electrocoagulation, the most efficient method of hemostasis restoration is the use of hemostatic agents. Although there are numerous products on the market, there is still a need for biomaterials that are capable of fast and efficient bleeding management without affecting wound closure or embolism. Chitosan is known for its hemostatic activity; however, its quite poor mechanical properties and heterogenous chemical composition still needs some improvements to become superior compared to biological adhesives. The following study deals with the preparation and evaluation of chitosan-derived natural biomaterials containing Kalanchoe pinnata extract with the potential application as a blood-clotting agent. The materials were obtained under microwave-assisted conditions in two different forms (granules/dressing), whose chemical structure and morphology were studied. Their antioxidant properties have been proven. The chitosan-derived hemostatic agents exhibited superior blood sorption abilities and lack of cytotoxicity to L929 mouse fibroblasts. The study also showed the differences in biological properties depending on their preparation method. The potential mechanism of action was proposed as well as their potential in hemostasis revival.

Excessive blood loss is a leading cause of mortality among soldiers and accident victims. The wound healing process typically ranges from three weeks to several months, with disruptions in healing stages potentially prolonging recovery time. Chronic wounds may persist for years, creating a favorable environment for microbial growth. Chitosan, a derivative of chitin—the second most abundant biopolymer in nature—is obtained through deacetylation and exhibits mucoadhesive, analgesic, antioxidant, biodegradable, non-toxic, and biocompatible properties. Due to its hemostatic and regenerative support capabilities, chitosan is widely applied in the food, cosmetic, and agricultural industries; environmental protection; and as a key component in dressings for chronic wound healing. Notably, its antibacterial properties make it a promising candidate for novel biomaterials to replace traditional antibiotics and prevent the emergence of drug-resistant strains. The primary aim of this study was the chemical cross-linking of chitosan with the amino acids L-aspartic and L-glutamic acid in the presence of periclase (magnesium oxide) under microwave radiation conditions. Subsequent research stages involved the analysis of the samples’ physicochemical properties using SEM, FT-IR, XPS, atomic absorption spectrometry, swelling behavior (in water, SBF, and blood), porosity, and density. Biological assessments included biodegradation, cytotoxicity, and antibacterial activity against Escherichia coli and Staphylococcus aureus. The obtained results confirmed the high potential of the newly developed hemostatic agents for effective hemorrhage management under non-sterile conditions.

An increasing number of tooth replacement procedures ending with implant failure generates a great need for the delivery of novel biomedical solutions with appropriate mechanical characteristics that would mimic natural tissue and undergo biodegradation. This phenomenon constitutes a significant difficulty for scientists, since currently applied biomaterials dedicated for this purpose are based on stainless steel, Ti, and Ti and CoCr alloys. One of the most promising raw materials is magnesium, which has been proven to promote bone regeneration and accelerate the tissue healing process. Nevertheless, its high reactivity with body fluid components is associated with fast and difficult-to-control biocorrosion, which strongly limits the application of Mg implants as medical devices. The achievement of appropriate functionality, both physiochemical and biological, to enable the commercial use of Mg biomaterials is possible only after their superficial modification. Therefore, the obtainment of uniform, reproducible coatings increasing resistance to the aqueous environment of the human body combined with a nanostructured surface that enhances implant–cell behaviors is an extremely important issue. Herein, we present a successful strategy for the modification of Mg implants via the PEO process, resulting in the obtainment of biomaterials with lower corrosion rates and superior biological properties, such as the promotion of extracellular matrix formation and a positive impact on the proliferation of MG-63 cells. The implants were investigated regarding their chemical composition using the FT-IR and XRD methods, which revealed that MgO layer formation, as well as the incorporation of electrolyte components such as fluorine and silica, were responsible for the increased microhardness of the samples. An extensive study of the biomaterials’ morphology confirmed that successful surface modification led to a microporous structure suitable for the attachment and proliferation of cells. The three-layer nature of the newly-formed coatings, typical for PEO modification, was confirmed via cross-section analysis. A biocorrosion and biodegradation study proved that applied modification increased their resistance to body fluids. The cell culture study performed herein confirmed that the correct adjustment of modification parameters results in a lack of cytotoxicity of the magnesium implants, cell proliferation enhancement, and improvement in extracellular matrix formation.

This study presents the development and comprehensive evaluation of magnesium-based implants with surface modifications using selected polymers and bioactive compounds. The implants were fabricated via plasma electrolytic oxidation (PEO), followed by the application of chitosan, polydopamine (PDA), and gold nanoparticles as bioactive surface coatings. In vitro experiments, including FT-IR spectroscopy, scanning electron microscopy (SEM), wettability tests, biodegradation assays in simulated body fluid (SBF), electrochemical corrosion analysis, and cytotoxicity tests using MG-63 osteoblast-like cells, were employed to assess the physicochemical and biological properties of the materials. The PEO + PDA-modified samples demonstrated the highest corrosion resistance (−1.15 V corrosion potential), enhanced cell viability (~95%), and favorable surface wettability (contact angle ~12.5°), outperforming other tested configurations. These findings suggest that PEO combined with PDA offers a synergistic effect, leading to superior biocompatibility and degradation control compared to unmodified magnesium or single-coating strategies. The developed implants hold promise for orthopedic applications requiring biodegradable, bioactive, and cytocompatible materials.

Given the increasing demand for biocompatible implant materials in regenerative engineering, novel surface modification techniques are essential to enhance tissue integration, durability, and corrosion resistance. This study investigates the application of plasma electrolytic oxidation (PEO), a high-voltage anodic oxidation technique, for the surface modification of magnesium (Mg) implants. The research emphasizes both functionality enhancement and process sustainability, adhering to green chemistry principles. A comprehensive analysis was conducted to evaluate the physicochemical and biological properties of the modified surfaces. The chemical structure of the coatings was characterized using Fourier-transform infrared spectroscopy (FT-IR) and atomic absorption spectroscopy (ASA). Surface morphology and composition were examined via scanning electron microscopy (SEM), while wettability was assessed through contact angle measurements. Additionally, biodegradation and biocorrosion studies were performed to evaluate stability, and cytotoxicity was tested using MG-63 human osteosarcoma cells. Results demonstrated that carefully optimized PEO process parameters, combined with appropriate electrolyte compositions, enabled the formation of MgO coatings with significantly enhanced stability, reduced biocorrosion, and improved biocompatibility. These findings indicate the potential of surface-modified magnesium implants for advanced biomedical applications.